{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:37:12Z","timestamp":1772120232458,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.amjcard.2016.12.023","type":"journal-article","created":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T13:51:46Z","timestamp":1485352306000},"page":"1146-1152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Long-Term Comparative Outcomes of Patients With Peripheral Artery Disease With and Without Concomitant Coronary Artery Disease"],"prefix":"10.1016","volume":"119","author":[{"given":"Debbie C.","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gagan D.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehrin J.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen W.","family":"Waldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Laird","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezra A.","family":"Amsterdam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2016.12.023_bib1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/2047487313519344","article-title":"Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study","volume":"22","author":"Subherwal","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.amjcard.2016.12.023_bib2","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","article-title":"One-year cardiovascular event rates in outpatients with atherothrombosis","volume":"297","author":"Steg","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2016.12.023_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11606-006-5042-4","article-title":"Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease","volume":"12","author":"McDermott","year":"1997","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.amjcard.2016.12.023_bib4","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1161\/CIRCOUTCOMES.109.930735","article-title":"Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States","volume":"3","author":"Mahoney","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.amjcard.2016.12.023_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/MCA.0000000000000044","article-title":"Comparison of mortality in patients with coronary or peripheral artery disease following the first vascular intervention","volume":"25","author":"Pereg","year":"2014","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.amjcard.2016.12.023_bib6","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/CIR.0b013e31822e80c3","article-title":"2011 ACCF\/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline) a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"124","author":"Rooke","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2016.12.023_bib7","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1161\/CIRCULATIONAHA.106.174526","volume":"113","author":"Hirsch","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2016.12.023_bib8","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.jacc.2011.10.824","volume":"58","author":"Smith","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2016.12.023_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/CIRCULATIONAHA.110.003954","article-title":"Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004","volume":"124","author":"Pande","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2016.12.023_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/1358836X0100600i103","article-title":"PAD awareness, risk, and treatment: new resources for survival\u2013the USA PARTNERS program","volume":"6","author":"Hirsch","year":"2001","journal-title":"Vasc Med Lond Engl"},{"key":"10.1016\/j.amjcard.2016.12.023_bib11","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/CIRCULATIONAHA.112.108787","article-title":"Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains","volume":"126","author":"Subherwal","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2016.12.023_bib12","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/clc.22217","article-title":"REACH registry investigators. Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH registry","volume":"36","author":"Rodriguez","year":"2013","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.amjcard.2016.12.023_bib13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/1358863X10373299","article-title":"Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH registry","volume":"15","author":"Suarez","year":"2010","journal-title":"Vasc Med"},{"key":"10.1016\/j.amjcard.2016.12.023_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1358863X13475836","article-title":"Gender-related variation in the clinical presentation and outcomes of critical limb ischemia","volume":"18","author":"McCoach","year":"2013","journal-title":"Vasc Med"},{"key":"10.1016\/j.amjcard.2016.12.023_bib15","doi-asserted-by":"crossref","first-page":"e000697","DOI":"10.1161\/JAHA.113.000697","article-title":"Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease","volume":"3","author":"Armstrong","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2016.12.023_bib16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1358863X15574321","article-title":"Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia","volume":"20","author":"Armstrong","year":"2015","journal-title":"Vasc Med"},{"key":"10.1016\/j.amjcard.2016.12.023_bib17","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jacc.2013.09.073","article-title":"Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia","volume":"63","author":"Westin","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2016.12.023_bib18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jvs.2015.01.051","article-title":"Association of dual-antiplatelet therapy with reduced major adverse cardiovascular events in patients with symptomatic peripheral arterial disease","volume":"62","author":"Armstrong","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.amjcard.2016.12.023_bib19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00000658-198402000-00016","article-title":"Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management","volume":"199","author":"Hertzer","year":"1984","journal-title":"Ann Surg"},{"issue":"Suppl B","key":"10.1016\/j.amjcard.2016.12.023_bib20","first-page":"3B","article-title":"Diffuse coronary disease and atherothrombosis: a rationale for long-term therapy to prevent recurrent ischemic events","volume":"15","author":"Bhatt","year":"2003","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.amjcard.2016.12.023_bib21","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/jama.2010.1322","article-title":"Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis","volume":"304","author":"Bhatt","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2016.12.023_bib22","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.jacc.2005.09.074","article-title":"Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease","volume":"47","author":"Feringa","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2016.12.023_bib23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2016.12.023_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2016.12.023_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2016.12.023_bib26","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","author":"Gerhard-Herman","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2016.12.023_bib27","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/eurheartj\/ehl114","article-title":"Ankle-brachial index and extent of atherothrombosis in 8891 patients with or at risk of vascular disease: results of the international AGATHA study","volume":"27","author":"Fowkes","year":"2006","journal-title":"Eur Heart J"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914917300449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914917300449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T17:53:18Z","timestamp":1536083598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914917300449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0002914917300449"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2016.12.023","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727385953.793533759","asserted-by":"object"}]},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Comparative Outcomes of Patients With Peripheral Artery Disease With and Without Concomitant Coronary Artery Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2016.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}